Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

This study is currently recruiting participants.
Verified June 2011 by Sun Yat-sen University
Sponsor:
Collaborator:
Beijing Fresenius Kabi Pharmaceutical Co
Information provided by:
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01255020
First received: August 11, 2010
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)